Cancer genomics: from discovery science to personalized medicine, Nat Med, vol.17, p.297, 2011. ,
Translational research in oncology-10 years of progress and future prospects, Nat Rev Clin Oncol, vol.11, p.649, 2014. ,
Precision oncology in the age of integrative genomics, Nat Biotechnol, vol.36, issue.1, pp.46-60, 2018. ,
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO scale for clinical Actionability of molecular targets (ESCAT), Ann Oncol, vol.29, issue.9, pp.1895-902, 2018. ,
Molecular screening programs in different countries: what we learned and perspectives, Curr Opin Oncol, vol.31, issue.5, pp.445-53, 2019. ,
Implementation of a molecular tumor board: the impact on treatment decisions for 35 patients evaluated at Dartmouth-Hitchcock Medical Center, Oncologist, vol.20, issue.9, pp.1011-1019, 2015. ,
The fuzzy world of precision medicine: deliberations of a precision medicine tumor board, Pers Med, vol.14, issue.1, pp.37-50, 2017. ,
A rising tide lifts all boats": establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease, BMC Med Genomics, vol.9, issue.1, p.71, 2016. ,
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery, Oncotarget, vol.8, issue.16, pp.27145-54, 2017. ,
Molecular tumor boards: ethical issues in the new era of data medicine, Sci Eng Ethics, vol.24, issue.1, pp.307-329, 2018. ,
Metastatic breast Cancer with ESR1 mutation: clinical management considerations from the molecular and precision medicine (MAP) tumor Board at Massachusetts General Hospital, Oncologist, vol.21, issue.9, pp.1035-1075, 2016. ,
Key lessons learned from Moffitt's molecular tumor board: the clinical genomics action committee experience, Oncologist, vol.22, issue.2, pp.144-51, 2017. ,
Integrating genomics into clinical pediatric oncology using the molecular tumor Board at the Memorial Sloan Kettering Cancer Center, Pediatr Blood Cancer, vol.63, issue.8, pp.1368-74, 2016. ,
Molecular tumor board: the University of California san Diego Moores Cancer Center experience, Oncologist, vol.19, issue.6, pp.631-637, 2014. ,
Implementation and utilization of the molecular tumor board to guide precision medicine, Oncotarget, vol.8, issue.34, pp.57845-54, 2017. ,
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer, ESMO Open, vol.3, issue.5, p.398, 2018. ,
Precision oncology based on omics data: The NCT Heidelberg experience, Int J Cancer, vol.141, issue.5, pp.877-86, 2017. ,
Molecular tumor boards: realizing precision oncology therapy, Clin Pharmacol Ther, vol.103, issue.2, pp.206-215, 2018. ,
Implementing a comprehensive translational oncology platform: from molecular testing to actionability, J Transl Med, vol.16, issue.1, p.358, 2018. ,
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers, Oncotarget, vol.7, issue.35, pp.56491-500, 2016. ,
Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study, JCO Precis Oncol, vol.2, pp.1-14, 2018. ,
Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board, JCO Precis Oncol, 2017. ,
, Case study research and applications: design and methods, p.352, 2017.
OncoKB: a precision oncology knowledge base, JCO Precis Oncol, 2017. ,
Utility of the JAX clinical knowledgebase in capture and assessment of complex genomic cancer data, Npj Precis Oncol, vol.3, issue.1, p.2, 2019. ,
A review of precision oncology Knowledgebases for determining the clinical Actionability of genetic variants, Front Cell Dev Biol, vol.8, p.48, 2020. ,
Organizing knowledge to enable personalization of medicine in cancer, Genome Biol, vol.15, issue.8, p.438, 2014. ,
Tumour heterogeneity and resistance to cancer therapies, Nat Rev Clin Oncol, vol.15, issue.2, pp.81-94, 2018. ,
Molecular tumor boards: current practice and future needs, Ann Oncol Off J Eur Soc Med Oncol, vol.28, issue.12, pp.3070-3075, 2017. ,
Teaming to innovate ,
Cross-boundary teaming for innovation: integrating research on teams and knowledge in organizations, Hum Resour Manag Rev, vol.28, issue.4, pp.347-60, 2018. ,
The evidence framework for precision cancer medicine, Nat Rev Clin Oncol, vol.15, issue.3, pp.183-92, 2018. ,
Managing customization in health care: a framework derived from the services sector literature, Health Policy, vol.117, issue.2, pp.216-243, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01509885
Customizing customization, Sloan Manag Rev, vol.38, issue.1, pp.21-30, 1996. ,
What 'patient-centered' should mean: confessions of an extremist, Health Aff (Millwood), vol.28, issue.4, pp.555-65, 2009. ,
Why the nation needs a policy push on patient-centered health care, Health Aff (Millwood), vol.29, issue.8, pp.1489-95, 2010. ,
Team-based care: views from community health center staff, Soc Work Health Care, vol.57, issue.4, pp.284-99, 2018. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations